| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Heart and Circulatory Physiology, Vol 272, Issue 5 2115-H2122, Copyright © 1997 by American Physiological Society
ARTICLES |
D. G. Parkes, J. Vaughan, J. Rivier, W. Vale and C. N. May
Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Parkville, Victoria, Australia. dparkes@amylin.com
Urocortin (Ucn) is a recently isolated peptide related to the corticotropin-releasing factor (CRF) family, which can produce hemodynamic and hormonal actions in conscious rats. This study examined in detail the cardiovascular actions of Ucn and CRF after intravenous injection in chronically instrumented, conscious sheep. Injection of Ucn produced dose-dependent changes in cardiac contractility [rate of increase of aortic flow (dF/dt)], maximum aortic flow (Fmax), mean arterial pressure (MAP), heart rate (HR), cardiac output (CO), and coronary blood flow (CF). Ucn injected at 100 micrograms produced a potent increase in dF/dt, from 909 +/- 44 to a maximum of 1,849 +/- 901.min-1.s-1, and in Fmax, from 25.5 +/- 0.8 to 36.6 +/- 1.4 l/min. Cardiac contractility increased within 30 min of injection and remained significantly elevated for up to 24 h. MAP increased from 78 +/- 2 to 90 +/- 3 mmHg, and HR increased from 73 +/- 4 to 103 +/- 9 beats/min. CO rose from 5.0 +/- 0.1 to 5.8 +/- 0.2 l/min, whereas central venous pressure, total peripheral conductance, and stroke volume were unchanged. All Ucn-induced cardiovascular effects were inhibited by prior treatment with the CRF antagonist alpha-helical CRF-(9-41). Equimolar doses of CRF produced little change in any hemodynamic parameter. Both peptides increased plasma levels of adrenocorticotropin and cortisol, with Ucn having a more potent effect than CRF. We have shown for the first time that Ucn can produce potent and long-lasting actions to elevate cardiac contractility in conscious animals.
This article has been cited by other articles:
|
|
 |
|
  D. J. Penny, J. P. Mynard, and J. J. Smolich Aortic wave intensity analysis of ventricular-vascular interaction during incremental dobutamine infusion in adult sheep Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H481 - H489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Rademaker, C. J. Charles, and A. M. Richards Urocortin 1 administration from onset of rapid left ventricular pacing represses progression to overt heart failure Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1536 - H1544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Townsend, S. M. Davidson, S. J. Clarke, I. Khaliulin, C. J. Carroll, T. M. Scarabelli, R. A. Knight, A. Stephanou, D. S. Latchman, and A. P. Halestrap Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H928 - H938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Florio, G. Calonaci, F. M. Severi, M. Torricelli, C. Bocchi, G. Fiore, E. A. Linton, and F. Petraglia Reduced Maternal Plasma Urocortin Concentrations and Impaired Uterine Artery Blood Flow at Human Mid Pregnancy Reproductive Sciences, April 1, 2005; 12(3): 191 - 194. [Abstract] [PDF]
|
|
|
|
|
|
J. M. Gordon, G. J. Dusting, O. L. Woodman, and R. H. Ritchie Cardioprotective action of CRF peptide urocortin against simulated ischemia in adult rat cardiomyocytes Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H330 - H336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Schulman, D. S. Latchman, and D. M. Yellon Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1481 - H1488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Bale, F. J. Giordano, R. P. Hickey, Y. Huang, A. K. Nath, K. L. Peterson, W. W. Vale, and K.-F. Lee Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization PNAS, May 15, 2002; (2002) 102187099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Shade, J. R. Blair-West, K. D. Carey, L. J. Madden, R. S. Weisinger, J. E. Rivier, W. W. Vale, and D. A. Denton Ingestive responses to administration of stress hormones in baboons Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R10 - R18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kihara, M. Fujimura, I. Yamamoto, E. Itoh, A. Inui, and M. Fujimiya Effects of central and peripheral urocortin on fed and fasted gastroduodenal motor activity in conscious rats Am J Physiol Gastrointest Liver Physiol, March 1, 2001; 280(3): G406 - G419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nishikimi, A. Miyata, T. Horio, F. Yoshihara, N. Nagaya, S. Takishita, C. Yutani, H. Matsuo, H. Matsuoka, and K. Kangawa Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H3031 - H3039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Parkes and C. N. May Urocortin: A Novel Player in Cardiac Control Physiology, October 1, 2000; 15(5): 264 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Brar, A. K. Jonassen, A. Stephanou, G. Santilli, J. Railson, R. A. Knight, D. M. Yellon, and D. S. Latchman Urocortin Protects against Ischemic and Reperfusion Injury via a MAPK-dependent Pathway J. Biol. Chem., March 17, 2000; 275(12): 8508 - 8514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Weisinger, J. R. Blair-West, P. Burns, D. A. Denton, M. J. McKinley, B. Purcell, W. Vale, J. Rivier, and K. Sunagawa The inhibitory effect of hormones associated with stress on Na appetite of sheep PNAS, March 14, 2000; 97(6): 2922 - 2927. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
